Close Menu

NEW YORK (GenomeWeb) – DiaCarta today announced it raised $8 million in a Series A financing round. 

Proceeds will go toward commercialization of its products and the expansion of its portfolio, it said, adding the financing came from BioVeda China Fund. In conjunction with BVCF's financing, Weixin Xu, a principal at the venture capital fund, will join DiaCarta's board.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.